MBIO Mustang Bio Inc

Price (delayed)

$0.3288

Market cap

$4.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.4

Enterprise value

$4.8M

Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare ...

Highlights
The company's debt has shrunk by 92% YoY and by 4% QoQ
MBIO's EPS has surged by 53% year-on-year and by 27% since the previous quarter
MBIO's equity has dropped by 117% year-on-year
The quick ratio has shrunk by 90% YoY and by 32% QoQ

Key stats

What are the main financial stats of MBIO
Market
Shares outstanding
12.51M
Market cap
$4.11M
Enterprise value
$4.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$37.17M
EBITDA
-$35.1M
Free cash flow
-$31.05M
Per share
EPS
-$4.4
Free cash flow per share
-$2.76
Book value per share
-$0.48
Revenue per share
$0
TBVPS
$1.3
Balance sheet
Total assets
$14.59M
Total liabilities
$19.54M
Debt
$2.4M
Equity
-$4.94M
Working capital
-$8.2M
Liquidity
Debt to equity
-0.48
Current ratio
0.53
Quick ratio
0.48
Net debt/EBITDA
-0.02
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-195.6%
Return on equity
-1,243.2%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBIO stock price

How has the Mustang Bio stock price performed over time
Intraday
6.06%
1 week
-3.29%
1 month
-34.24%
1 year
-93.06%
YTD
-75.64%
QTD
-30.04%

Financial performance

How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$38.17M
Net income
-$40.1M
Gross margin
N/A
Net margin
N/A
MBIO's operating income is up by 48% YoY and by 23% from the previous quarter
MBIO's net income is up by 46% year-on-year and by 22% since the previous quarter

Growth

What is Mustang Bio's growth rate over time

Valuation

What is Mustang Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS has surged by 53% year-on-year and by 27% since the previous quarter
MBIO's equity has dropped by 117% year-on-year

Efficiency

How efficient is Mustang Bio business performance
The company's return on equity has shrunk by 187% QoQ
MBIO's ROA has plunged by 161% YoY and by 34% from the previous quarter

Dividends

What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBIO.

Financial health

How did Mustang Bio financials performed over time
Mustang Bio's total assets is 25% less than its total liabilities
The quick ratio has shrunk by 90% YoY and by 32% QoQ
Mustang Bio's current ratio has shrunk by 89% YoY and by 28% QoQ
The company's debt is 148% higher than its equity
The debt to equity has shrunk by 145% YoY and by 102% QoQ
MBIO's equity has dropped by 117% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.